Your browser doesn't support javascript.
loading
Complete metabolic tumour response, assessed by 18-fluorodeoxyglucose positron emission tomography (18FDG-PET), after induction chemotherapy predicts a favourable outcome in patients with locally advanced non-small cell lung cancer (NSCLC).
Decoster, L; Schallier, D; Everaert, H; Nieboer, K; Meysman, M; Neyns, B; De Mey, J; De Grève, J.
Affiliation
  • Decoster L; Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, 1090 Jette, Belgium.
Lung Cancer ; 62(1): 55-61, 2008 Oct.
Article in En | MEDLINE | ID: mdl-18394750

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article

Full text: 1 Database: MEDLINE Main subject: Carcinoma, Non-Small-Cell Lung / Radiopharmaceuticals / Fluorodeoxyglucose F18 / Positron-Emission Tomography / Lung Neoplasms Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Year: 2008 Type: Article